Esperion Therapeutics, Inc.
ESPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51,745 | -$209,248 | -$233,659 | -$269,108 |
| Dep. & Amort. | $63 | $164 | $500 | $612 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11,993 | $11,958 | $15,215 | $24,306 |
| Change in WC | -$60,530 | $13,675 | -$3,373 | -$52,513 |
| Other Non-Cash | $76,565 | $47,964 | $46,490 | $32,894 |
| Operating Cash Flow | -$23,654 | -$135,487 | -$174,827 | -$263,809 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$317 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$59,897 | -$50,484 |
| Inv. Sales/Matur. | $0 | $42,500 | $68,001 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$317 | $42,500 | $8,104 | -$50,484 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $35,014 | $0 | $0 | -$440 |
| Stock Issued | $91,185 | $56,876 | $90,849 | $218,688 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$39,715 | -$6,416 | -$58,243 | $49,975 |
| Financing Cash Flow | $86,484 | $50,460 | $32,606 | $268,223 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $62,513 | -$42,527 | -$134,117 | -$46,070 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $82,248 | $124,775 | $258,892 | $304,962 |
| End Cash | $144,761 | $82,248 | $124,775 | $258,892 |
| Free Cash Flow | -$23,971 | -$135,487 | -$174,827 | -$263,809 |